Ευρωπαϊκή Ένωση -
Ισλανδικά -
EMA (European Medicines Agency)
vafseo
akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - sýklalyf - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
metoprolol alvogen (metoprolol ratiopharm) forðatafla 95 mg
alvogen ehf. - metoprololum súkkínat - forðatafla - 95 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
bloxazoc forðatafla 100 mg
krka d.d. novo mesto - metoprololum súkkínat - forðatafla - 100 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
metoprolol alvogen (metoprolol ratiopharm) forðatafla 190 mg
alvogen ehf. - metoprololum súkkínat - forðatafla - 190 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
logimax forte forðatafla 10 mg + 100 mg
recordati ireland limited* - metoprololum súkkínat; felodipinum inn - forðatafla - 10 mg + 100 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
logimax forðatafla 5 mg + 50 mg
recordati ireland limited* - metoprololum súkkínat; felodipinum inn - forðatafla - 5 mg + 50 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
bloxazoc forðatafla 25 mg
krka d.d. novo mesto - metoprololum súkkínat - forðatafla - 25 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
bloxazoc forðatafla 200 mg
krka d.d. novo mesto - metoprololum súkkínat - forðatafla - 200 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
bloxazoc forðatafla 50 mg
krka d.d. novo mesto - metoprololum súkkínat - forðatafla - 50 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
metoprolol alvogen (metoprolol ratiopharm) forðatafla 23,75 mg
alvogen ehf. - metoprololum súkkínat - forðatafla - 23,75 mg